Global Clinical Decision Support Systems Devices Market Outlook 2031:
The global clinical decision support systems devices market size was valued at USD XX Billion in 2022 and is projected to reach USD XX Billion by 2031, expanding at a CAGR of XX% during the forecast period 2023 - 2031. Clinical decision support systems (CDSS) devices is a health information technology and a computerized-based program that analyzes data within electronic health recorders (EHRs).
CDSS device provides knowledge related to person-specific information, intelligently filtered or presented at appropriate times to staff, patients, clinicians, by enhancing health and healthcare. It is used for prompts and reminders that assist healthcare providers in implementing evidence-based clinical guidelines at the point of care.
CDSS devices offer benefits such as reducing the risk of medication errors, providing the entire care team with consistent, reliable information, providing access to all information at one place, reducing misdiagnoses, and improving efficiency and patient throughput.
Clinical Decision Support Systems Devices Market Trends, Drivers, Restraints, and Opportunities
- Rising demand for reduced healthcare expenditure, increasing initiatives by governments, and support in the adoption of healthcare IT solutions are boosting the market.
- Increasing adoption of CDSS devices-based electronic health recorders, and prominent used of big data and mHealth tools are fueling the market.
- Growing medication errors required the need of CDSS devices in reducing human errors with improved quality, which is driving the market.
- High cost associated with implementation of CDSS devices in infrastructure, and concerns related to data security and privacy in cloud-based CDSS devices are restricting the market growth.
- Lack of skilled technicians and professionals, and lack of interoperability are hampering the growth of the market.
- Growth in technological advancement, innovation, and social media integration are creating opportunities for the growth of the market.
Scope of the Clinical Decision Support Systems Devices Market report
The report on the global clinical decision support systems devices market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Clinical Decision Support Systems Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Components [Hardware Software, and Services], Products (Integrated CDSS [With CPOE, With HER, and Both CPOE and HER], and Standalone CDSS), Types (Therapeutic CDSS and Diagnostic CDSS), Models (Knowledge-based CDSS [Fuzzy Logic-based, Rule-based, and Evidence-based], and Non-knowledge-based CDSS [Artificial Neural Networks and Genetic Algorithms]), Level of Interactivity (Active CDSS and Passive CDSS), Delivery Modes (On-premise CDSS and Cloud-based CDSS), Applications (Conventional CDSS and Advanced CDSS), Setting (Impatient Setting and Ambulatory Care Setting), Uses (Medical Diagnosis, Alerts and Reminders, Prescription Decision Support, Information Retrieval, and Others)
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report
Allscripts Healthcare, LLC, athenahealth, Inc, Cerner Corporation, Change Healthcare, CyreMD Healthcare, EBSCO Information Services, eClinicalWorks, Epic Systems Corporation, IBM, Koninklijke Philips N.V., Medical Information Technology, Inc, NXGN Management, LLC, Wolters Kluwer N.V., and Zunx Health, Inc.
Clinical Decision Support Systems Devices Market Segment Insights:
CDSS services to drive the market
In terms of components, the clinical decision support systems devices market is segmented into hardware, software, and services. The services segment held a considerable share of the market in 2020, as it aided medical staff and clinicians in the decision-making process.
CDSS services are used as tools of data or information management that are further utilized as per requirement. CDSS services maintain the privacy and security of patient data without any fear of technical algorithm that creates complexities in the decision-making process.
Integrated CDSS to drive the market
Based on products, the clinical decision support systems devices market is fragmented into integrated CDSS and standalone CDSS. Integrated CDSS is sub-segmented into integrated CDSS with CPOE, with HER, and both CPOE and HER. The integrated CDSS segment constituted a significant market share in 2020 and is projected to expand at a rapid rate during the forecast period.
The growth in the integrated CDSS segment is associated with availability of various products that are integrated with CDSS. These integrated CDSS devices include CDSS integrated with CPOE, CDSS integrated with HER, and CDSS integrated with both CPOE and HER. HER (Electronic Health Recorder) is majorly used by healthcare staff for treating and supporting patients.
Diagnostic CDSS segment to drive the market
On the basis of types, the clinical decision support systems devices market is segregated into therapeutic CDSS and diagnostic CDSS. The diagnostic CDSS segment is expected to hold a significant share of the market during the forecast period, as it improves patient care by eliminating unnecessary testing, enhancing safety, and avoiding dangerous and costly complications.
Knowledge-based CDSS segment to drive the market
On the basis of models, the clinical decision support systems devices market is segregated into knowledge-based CDSS and non-knowledge-based CDSS. The knowledge-based CDSS segment is sub-segmented into fuzzy logic-based, rule-based, and evidence-based. The non-knowledge-based CDSS segment is sub-segmented into artificial neural networks and genetic algorithms.
The knowledge-based CDSS segment is expected to hold a significant share of the market during the forecast period, due to their functional benefits such as helping clinicians to make decisions in the face of uncertainties with the help of knowledge-based reasoning model. This system causes less errors as compared to the non-knowledge-based system.
Active CDSS segment to drive the market
On the basis of level of interactivity, the clinical decision support systems devices market is segregated into active CDSS and passive CDSS. The active CDSS segment is expected to hold a significant share of the market during the forecast period, due to growing need to control cost and expenditure of healthcare, especially in ambulatory care setting.
Active CDSS provides information after comparison with the existing patient data with the programed guidelines and protocols on knowledge base that help clinicians to take decisions and provide guidance to patients.
Cloud-based CDSS segment to drive the market
On the basis of delivery modes, the clinical decision support systems devices market is segregated into on-premise CDSS and cloud-based CDSS. The on-premises CDSS segment is expected to hold a significant share of the market during the forecast period, owing to lack of trust by patients and concerns about data privacy.
The cloud-based CDSS deices segment is projected to grow in the near future, due to availability of cloud technology. The technology is expected to operate on remote servers, which make it less vulnerable to cyberattack. Furthermore, the cloud-based system does not require large storage space and computational power in devices.
Advanced CDSS segment to drive the market
On the basis of applications, the clinical decision support systems devices market is segregated into conventional CDSS and advanced CDSS. The advanced CDSS segment is expected to expand at a significant rate during the forecast period, as CDSS devices are highly adopted for checking contra-indication drugs and diseases.
Additionally, advanced CDSS offer benefits including guidance for medication-related laboratory testing, individualized dosing support during renal impairment, and providing effective usage.
Impatient segment to drive the market
On the basis of setting, the clinical decision support systems devices market is segregated into impatient setting and ambulatory care setting. The impatient setting segment is expected to hold a significant share of the market during the forecast period, as it is associated with high adoption for maintaining medical records of patients.
CDSS shortens inpatient length of stay in the hospital, improving consistency in providing services by continuity of care and follow-up, decrease adverse drug interacting, and reduce practice variation.
Decision Support segment to drive the market
On the basis of uses, the clinical decision support systems devices market is segregated into medical diagnosis, alerts and reminders, prescription decision support, information retrieval, and others. The decision support segment is expected to hold a large share of the market during the forecast period, due to the areas covered in decision making process related to patient health.
CDSS helps clinicians in complex-decision making, assisting and enabling healthcare providers for analyzing data, and prediction of outcome. Hence, the use of CDSS in decision support helps the CDSS device market to grow in the forecast period.
Improving regulatory framework in Asia Pacific to drive the market
In terms of regions, the global clinical decision support systems devices market is split into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America constituted a significant share of the market in 2020, due to mergers and acquisitions conducted by key market players.
The market in Asia Pacific is projected to expand at a significant CAGR during the forecast period, due to presence of a large geriatric population, high amount of chronic diseases burden, improving regulatory framework and polices, government initiatives and support towards maintenance of healthcare infrastructure and increasing focus by market players for developing innovative products, which is helping the market to grow in the region.
- Integrated CDSS
- With CPOE
- With HER
- Both CPOE and EHR
- Standalone CDSS
- Therapeutic CDSS
- Diagnostic CDSS
- Knowledge-based CDSS
- Fuzzy Logic-based
- Non-knowledge-based CDSS
- Artificial Neural Networks
- Genetic Algorithms
By Level of Interactivity
By Delivery Modes
- On-premise CDSS
- Cloud-based CDSS
- Conventional CDSS
- Advanced CDSS
- Impatient Setting
- Ambulatory Care Setting
- Medical Diagnosis
- Alerts and Reminders
- Prescription Decision Support
- Information Retrieval
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
By Key Players
- Allscripts Healthcare, LLC
- athenahealth, Inc
- Cerner Corporation
- Change Healthcare
- CyreMD Healthcare
- EBSCO Information Services
- Epic Systems Corporation
- Koninklijke Philips N.V.
- Medical Information Technology, Inc
- NXGN Management, LLC
- Wolters Kluwer N.V.
- Zunx Health, Inc
Key players in the global clinical decision support systems devices market include Allscripts Healthcare, LLC, athenahealth, Inc, Cerner Corporation, Change Healthcare, CyreMD Healthcare, EBSCO Information Services, eClinicalWorks, Epic Systems Corporation, IBM, Koninklijke Philips N.V., Medical Information Technology, Inc, NXGN Management, LLC, Wolters Kluwer N.V., and Zunx Health, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.